Semenzato G, Pandolfi F, Chisesi T, De Rossi G, Pizzolo G, Zambello R, Trentin L, Agostini C, Dini E, Vespignani M
Department of Clinical Medicine, University of Padova, Italy.
Cancer. 1987 Dec 15;60(12):2971-8. doi: 10.1002/1097-0142(19871215)60:12<2971::aid-cncr2820601220>3.0.co;2-o.
A multiparameter analysis, which included the evaluation of clinical features, cell morphology, karyotype, phenotypic and functional immunologic findings, and T-cell receptor beta-chain configuration was performed on 34 patients with lymphoproliferative disease of granular lymphocytes (LDGL). The two-fold aim of the study was to identify the most useful tools that would more accurately characterize these patients and to deal with the problem of classifying these lymphoproliferative disorders. The data presented in this article suggest that a single parameter may not be sufficient to define the nature of the proliferating cells or to predict the clinical course of the disease and prognosis for the patient. The use of a multiparameter approach, however, may reach this goal, thus providing important prognostic and therapeutic information. Our study supports the concept that lymphoproliferative disease of granular lymphocytes is a heterogeneous disorder that ranges from indolent and possibly reactive conditions to the manifestation of aggressive malignancies.
对34例颗粒淋巴细胞增殖性疾病(LDGL)患者进行了多参数分析,包括临床特征、细胞形态、核型、表型和功能免疫结果以及T细胞受体β链构型的评估。该研究的双重目的是确定最有用的工具,以便更准确地对这些患者进行特征描述,并解决这些淋巴细胞增殖性疾病的分类问题。本文所呈现的数据表明,单一参数可能不足以定义增殖细胞的性质或预测疾病的临床进程及患者的预后。然而,采用多参数方法可能会实现这一目标,从而提供重要的预后和治疗信息。我们的研究支持这样一种观点,即颗粒淋巴细胞增殖性疾病是一种异质性疾病,范围从惰性且可能为反应性状态到侵袭性恶性肿瘤的表现。